The cell therapy market size is forecasted to increase by USD 21.061 billion from 2021 to 2026, at a CAGR of 56.79%, according to the recent market study by Technavio. The growth of the market will be driven by the increasing prevalence of chronic diseases, limitations in traditional organ transplantations fueling demand for cell therapies, and increasing funding in cell-based research. North America will account for 40% of the market growth during the forecast period. The growth of the regional
AVITA Medical, Inc. (NASDAQ:RCEL – Get Free Report) was the target of a large decrease in short interest in October. As of October 15th, there was short interest totalling 732,000 shares, a decrease of 19.6% from the September 30th total of 910,100 shares. Based on an average daily volume of 164,700 shares, the days-to-cover ratio […]
/PRNewswire/ The cell therapy market size is forecasted to increase by USD 21.061 billion from 2021 to 2026, at a CAGR of 56.79%, according to the recent.
Avita Medical (RCEL) Announces Prelim. Third Quarter Financial Highlights and Secures up to $90 million of Non-Dilutive Debt Financing streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.